|
|
(159 intermediate revisions not shown) |
Line 1: |
Line 1: |
| {{Template:EPFL2013Header}} | | {{Template:EPFL2013Header}} |
- | '''Taxi.Coli: smart drug delivery''' | + | |
| + | <html><script type='text/javascript'>window.titleOverride = "Taxi.Coli: smart drug delivery";</script></html> |
| + | |
| + | <html><iframe width="640" height="480" src="//www.youtube.com/embed/2oGyBahBHuI" frameborder="0" allowfullscreen style="margin-left: 60px"></iframe></html> |
| + | |
| + | <br><br><br> |
| + | We are proud to participate in iGEM 2013 and are excited to present<br> |
| + | '''Taxi.Coli'''. |
| + | <br> |
| + | Taxi.Coli is a highly flexible and adaptable smart drug delivery system.<br> |
| + | We want to use E.coli as a ''Taxi'', that expresses streptavidin on its surface as ''Seats'' for the ''Passengers'', which are the biotinylated nanoparticles that contain a drug. Once Taxi.Coli arrives at ''the Address'', a specific environment, it will produce an enzyme that degrades the nanoparticles, releasing the incorporated drug ''the passenger gets out of the car''. <br>Our effort will be limited to a proof of principle, but one can imagine a wide range of future applications. |
| + | |
| + | |
| + | <br> |
| + | |
| + | |
| + | |
| + | |
| + | |
| + | <html> |
| + | <div class='box-outer'> |
| + | <a href='https://2013.igem.org/Team:EPF_Lausanne/Overview'> |
| + | <div class='box box-1'> |
| + | <table> |
| + | <tr> |
| + | <td class='box-image'> |
| + | <img src='https://static.igem.org/mediawiki/2013/1/14/Team-EPF-Lausanne_Boxes_project.png' /> |
| + | </td> |
| + | </tr> |
| + | <tr> |
| + | <td class='box-text'> |
| + | Project |
| + | </td> |
| + | </tr> |
| + | </table> |
| + | </div> |
| + | </a> |
| + | <a href='https://2013.igem.org/Team:EPF_Lausanne/Team'> |
| + | <div class='box box-2'> |
| + | <table> |
| + | <tr> |
| + | <td class='box-image'> |
| + | <img src='https://static.igem.org/mediawiki/2013/5/55/Team-EPF-Lausanne_Boxes_team.png' /> |
| + | </td> |
| + | </tr> |
| + | <tr> |
| + | <td class='box-text'> |
| + | Team |
| + | </td> |
| + | </tr> |
| + | </table> |
| + | </div> |
| + | </a> |
| + | <a href='https://2013.igem.org/Team:EPF_Lausanne/Safety'> |
| + | <div class='box box-3'> |
| + | <table> |
| + | <tr> |
| + | <td class='box-image'> |
| + | <img src='https://static.igem.org/mediawiki/2013/3/3c/Team-EPF-Lausanne_Boxes_safety.png' /> |
| + | </td> |
| + | </tr> |
| + | <tr> |
| + | <td class='box-text'> |
| + | Safety |
| + | </td> |
| + | </tr> |
| + | </table> |
| + | </div> |
| + | </a> |
| + | <a href='https://2013.igem.org/Team:EPF_Lausanne/Outreach_Overview'> |
| + | <div class='box box-4'> |
| + | <table> |
| + | <tr> |
| + | <td class='box-image'> |
| + | <img src='https://static.igem.org/mediawiki/2013/e/e9/Team-EPF-Lausanne_Boxes_outreach.png' /> |
| + | </td> |
| + | </tr> |
| + | <tr> |
| + | <td class='box-text'> |
| + | Outreach |
| + | </td> |
| + | </tr> |
| + | </table> |
| + | </div> |
| + | </a> |
| + | </div> |
| + | |
| + | <!-- Mise en page --> |
| + | <div style='clear:both'></div> |
| + | </html> |
| + | |
| + | <html><div style='clear: both'></div></html> |
| + | <br /> |
| | | |
| <html> | | <html> |
Line 9: |
Line 101: |
| width: 300px; | | width: 300px; |
| float: right; | | float: right; |
- | margin-top: -50px;
| |
| margin-right: 5px; | | margin-right: 5px; |
| margin-left: 15px; | | margin-left: 15px; |
Line 16: |
Line 107: |
| </html> | | </html> |
| | | |
- | Researchers all over the world strive to improve the effectiveness of drugs. Emergent strategies such as "Targeted drug delivery" allow a more precise and localized administration of drugs. The aim of this method is to increase drug concentration in a specific location (e.g. a tumor); yet decreasing secondary effects on healthy tissues. This method reduces the frequency and dose of drug administration.
| + | <br> |
| + | <br> |
| | | |
- | EPFL team’s goal this year is to suggest a drug delivery strategy. The key word of this project is “adaptability”. Our motivation is to explore a way of using E.Coli as a drug carrier in a way that is highly modular; thereby suiting several applications and possibilities of disease treatment.
| + | <br> |
| | | |
- | Using the principles of synthetic biology we will bond nanoparticles containing a drug to E.coli using the biotin-streptavidin interaction. The engineered E.coli will target the site where the drug is required. Upon stimuli it starts to release a protease degrading the nanoparticles and hence delivers the drug.
| + | ==Achievements:== |
| + | - We can produce biotinylated nanoparticles<br> |
| + | - We can engineer E.coli expressing streptavidin (maybe even on the surface) to bind these nanoparticles<br> |
| + | - We can engineer E.coli to sense different values of pH<br> |
| + | - We can make E.coli express superfolded GFP constitutively<br> |
| + | - We can excite other students about synthetic biology<br> |
| + | |
| + | |
| + | |
| + | |
| + | |
| + | Please also visit our [https://www.facebook.com/groups/EPFL.IGEM2013/ Facebook page]! |
| + | |
| + | |
| + | <html><div style='clear: both'></div></html> |
| + | |
| + | <html> |
| + | <h2>Medal requirements</h2> |
| + | <h3>Bronze medal</h3> |
| + | <ul class="checkmark-list"> |
| + | <li>We registered the team and had fun in the competition.</li> |
| + | <li>We filled in the Judging form.</li> |
| + | <li>We described our project using the iGEM wiki and our parts using the Registry of Standard Biological Parts.</li> |
| + | <li>We plan to present a poster and talk at the iGEM Jamboree in Lyon.</li> |
| + | <li>We designed and submitted the following Biobricks BBa_K1111001, BBa_K1111002, BBa_K111103, BBa_K1111004, BBa_K1111005, BBa_K1111006, BBa_K1111007, BBa_K1111008, BBa_K1111009, BBa_K1111010, BBa_K1111011, BBa_K1111012, BBa_K1111013, BBa_K1111014.</li> |
| + | </ul> |
| + | <h3>Silver medal</h3> |
| + | <ul class="checkmark-list"> |
| + | <li>We experimentally validated that the Biobrick BBa_K1111005 works as expected.</li> |
| + | <li>We documented all our parts on the iGEM Registry of Standard Biological Parts.</li> |
| + | <li>We investigated the safety issues which could be raised by our project. Take a look at our safety page.</li> |
| + | </ul> |
| + | <h3>Gold medal</h3> |
| + | <ul class="checkmark-list"> |
| + | <li>We improved the function of the already existing Biobrick BBa_K523013 by extensively characterizing and documenting it. This will help future teams to use it.</li> |
| + | <li>We prepared an amazing synthetic biology kit which will be used at public events and high school visits at EPFL. Take a look at our Outreach page. </li> |
| + | <li>We organized a women and engineering's day at our university to promote women in science. </li> |
| + | <br><br> |
| + | <h3>European Jamboree Results</h3> |
| + | <ul class="checkmark-list"> |
| + | <li>SILVER MEDAL</li> |
| + | <li>ADVANCE TO WORLD CHAMPIONSHIP</li> |
| + | </ul> |
| + | </html> |
| + | <br> |
| + | <br> |
| + | <br> |
| | | |
| + | == Thanks to our sponsors == |
| + | Many thanks to our sponsors who made it possible for us to take part in this amazing competition. |
| + | <br> |
| + | [[File:Team-EPF-Lausanne sponso.jpg|center|550px]] |
| | | |
- | Taxi.Coli: smart drug delivery
| + | <br><br> |
- | EPF_Lausanne’s team is proud to participate to iGEM 2013 and excited to present their project: Taxi.Coli: smart drug delivery. The team’s vision is to build a biosynthetic drug delivery concept. The key word of this project is “adaptability”. Our goal is to explore a way of using E.Coli as a highly modular carrier, opening the gate to several applications and alternatives in disease treatments. Using the principles of synthetic biology, we engineered a gelatinase secreting E. Coli able to bind gelatin nanoparticles using a biotin-streptavidin interaction and release them in a corresponding location. The drug delivery system is built in three parts: 1) the nanoparticle binding and 2) the environment sensing that 3) triggers the gelatinase release of the engineered E. Coli, liberating the content of the nanoparticle. The nanoparticles made of gelatin are able to carry any type of organic compound leading to a wide range of applications.
| + | |
| {{Template:EPFL2013Footer}} | | {{Template:EPFL2013Footer}} |